Cargando…

Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study

BACKGROUND: China contributes to a significant proportion of the myopia in the world. The study aims to investigate the utilization of various correction methods and health service in urban China, and to estimate the cost of myopia treatment and prevention. In addition, we aimed to estimate the cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yingyan, Wen, Yuechun, Zhong, Hua, Lin, Senlin, Liang, Li, Yang, Yifang, Jiang, Huifen, Chen, Jian, Huang, Yan, Ying, Xiaohua, Resnikoff, Serge, Lu, Lina, Zhu, Jianfeng, Xu, Xun, He, Xiangui, Zou, Haidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934110/
https://www.ncbi.nlm.nih.gov/pubmed/35356656
http://dx.doi.org/10.7189/jogh.12.11003
_version_ 1784671792387850240
author Ma, Yingyan
Wen, Yuechun
Zhong, Hua
Lin, Senlin
Liang, Li
Yang, Yifang
Jiang, Huifen
Chen, Jian
Huang, Yan
Ying, Xiaohua
Resnikoff, Serge
Lu, Lina
Zhu, Jianfeng
Xu, Xun
He, Xiangui
Zou, Haidong
author_facet Ma, Yingyan
Wen, Yuechun
Zhong, Hua
Lin, Senlin
Liang, Li
Yang, Yifang
Jiang, Huifen
Chen, Jian
Huang, Yan
Ying, Xiaohua
Resnikoff, Serge
Lu, Lina
Zhu, Jianfeng
Xu, Xun
He, Xiangui
Zou, Haidong
author_sort Ma, Yingyan
collection PubMed
description BACKGROUND: China contributes to a significant proportion of the myopia in the world. The study aims to investigate the utilization of various correction methods and health service in urban China, and to estimate the cost of myopia treatment and prevention. In addition, we aimed to estimate the cost of productivity loss due to myopia. METHODS: The study was a cross-sectional investigation carried out in urban areas in three provinces located in the east (Shanghai), middle (Anhui) and west part (Yunnan) of China, in 2016. A total of 23819 people aged between 5 to 50 years were included. Health utilization and the cost of myopia were analyzed from patients’ perspective. RESULTS: The total number of people with myopia in the urban China was estimated to be 143.6 million. The correction rate was 89.5%, 92.1%, and 92.7% for Anhui, Shanghai, and Yunnan (χ(2) = 19.5, P < 0.01). Over the recent year, 20.6%, 16.8%, and 28.8% of myopic subjects visited hospital due to myopia, in Anhui, Shanghai and Yunnan. The annual cost of treatment and prevention of myopia was 10.1 billion US dollar (US$, floating from 9.2 to 11.2 billion US$), and the cost per person was 69US$. The annual cost of loss of productivity was estimated to be 6.7 billion US$ for those with mild to moderate visual impairment (floating from 6.1 to 7.4 billion US$), and 9.4 billion US$ (floating from 8.5 to 10.4 billion US$) for those with severe visual impairment to blindness. Therefore, the total economic burden of myopia was estimated as 173.6 billion CNY (26.3 billion US$). CONCLUSIONS: The present study shows that myopia leads to substantial economic burden in China. The loss of productivity caused by myopia is an important part of the disease burden compared to the cost of correction and treatment paid by individuals. Therefore, the focus of myopia prevention and control should be to decrease the myopia prevalence, and prevent the uncorrected refractive errors and the irreversible damage of visual acuity by high myopia.
format Online
Article
Text
id pubmed-8934110
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Global Health
record_format MEDLINE/PubMed
spelling pubmed-89341102022-03-29 Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study Ma, Yingyan Wen, Yuechun Zhong, Hua Lin, Senlin Liang, Li Yang, Yifang Jiang, Huifen Chen, Jian Huang, Yan Ying, Xiaohua Resnikoff, Serge Lu, Lina Zhu, Jianfeng Xu, Xun He, Xiangui Zou, Haidong J Glob Health Research Theme 7: Health Transitions in China BACKGROUND: China contributes to a significant proportion of the myopia in the world. The study aims to investigate the utilization of various correction methods and health service in urban China, and to estimate the cost of myopia treatment and prevention. In addition, we aimed to estimate the cost of productivity loss due to myopia. METHODS: The study was a cross-sectional investigation carried out in urban areas in three provinces located in the east (Shanghai), middle (Anhui) and west part (Yunnan) of China, in 2016. A total of 23819 people aged between 5 to 50 years were included. Health utilization and the cost of myopia were analyzed from patients’ perspective. RESULTS: The total number of people with myopia in the urban China was estimated to be 143.6 million. The correction rate was 89.5%, 92.1%, and 92.7% for Anhui, Shanghai, and Yunnan (χ(2) = 19.5, P < 0.01). Over the recent year, 20.6%, 16.8%, and 28.8% of myopic subjects visited hospital due to myopia, in Anhui, Shanghai and Yunnan. The annual cost of treatment and prevention of myopia was 10.1 billion US dollar (US$, floating from 9.2 to 11.2 billion US$), and the cost per person was 69US$. The annual cost of loss of productivity was estimated to be 6.7 billion US$ for those with mild to moderate visual impairment (floating from 6.1 to 7.4 billion US$), and 9.4 billion US$ (floating from 8.5 to 10.4 billion US$) for those with severe visual impairment to blindness. Therefore, the total economic burden of myopia was estimated as 173.6 billion CNY (26.3 billion US$). CONCLUSIONS: The present study shows that myopia leads to substantial economic burden in China. The loss of productivity caused by myopia is an important part of the disease burden compared to the cost of correction and treatment paid by individuals. Therefore, the focus of myopia prevention and control should be to decrease the myopia prevalence, and prevent the uncorrected refractive errors and the irreversible damage of visual acuity by high myopia. International Society of Global Health 2022-03-19 /pmc/articles/PMC8934110/ /pubmed/35356656 http://dx.doi.org/10.7189/jogh.12.11003 Text en Copyright © 2022 by the Journal of Global Health. All rights reserved. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Theme 7: Health Transitions in China
Ma, Yingyan
Wen, Yuechun
Zhong, Hua
Lin, Senlin
Liang, Li
Yang, Yifang
Jiang, Huifen
Chen, Jian
Huang, Yan
Ying, Xiaohua
Resnikoff, Serge
Lu, Lina
Zhu, Jianfeng
Xu, Xun
He, Xiangui
Zou, Haidong
Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
title Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
title_full Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
title_fullStr Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
title_full_unstemmed Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
title_short Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study
title_sort healthcare utilization and economic burden of myopia in urban china: a nationwide cost-of-illness study
topic Research Theme 7: Health Transitions in China
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934110/
https://www.ncbi.nlm.nih.gov/pubmed/35356656
http://dx.doi.org/10.7189/jogh.12.11003
work_keys_str_mv AT mayingyan healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT wenyuechun healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT zhonghua healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT linsenlin healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT liangli healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT yangyifang healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT jianghuifen healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT chenjian healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT huangyan healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT yingxiaohua healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT resnikoffserge healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT lulina healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT zhujianfeng healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT xuxun healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT hexiangui healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy
AT zouhaidong healthcareutilizationandeconomicburdenofmyopiainurbanchinaanationwidecostofillnessstudy